Applied Therapeutics Inc (APLT) concluded trading on Thursday at a closing price of $8.38, with 2.48 million shares of worth about $20.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 25.64% during that period and on September 25, 2024 the price saw a gain of about 3.39%. Currently the company’s common shares owned by public are about 114.85M shares, out of which, 86.00M shares are available for trading.
Stock saw a price change of 6.75% in past 5 days and over the past one month there was a price change of 41.08%. Year-to-date (YTD), APLT shares are showing a performance of 150.15% which increased to 308.78% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.79 but also hit the highest price of $9.39 during that period. The average intraday trading volume for Applied Therapeutics Inc shares is 2.40 million. The stock is currently trading 36.77% above its 20-day simple moving average (SMA20), while that difference is up 42.62% for SMA50 and it goes to 73.85% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Applied Therapeutics Inc (NASDAQ: APLT) currently have 114.85M outstanding shares and institutions hold larger chunk of about 79.93% of that.
The stock has a current market capitalization of $962.44M and its 3Y-monthly beta is at 2.03. It has posted earnings per share of -$1.32 in the same period. It has Quick Ratio of 2.30 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for APLT, volatility over the week remained 9.72% while standing at 9.64% over the month.
Stock’s fiscal year EPS is expected to rise by 32.73% while it is estimated to increase by 56.25% in next year.
Coverage by RBC Capital Mkts stated Applied Therapeutics Inc (APLT) stock as an Outperform in their note to investors on March 26, 2024, suggesting a price target of $12 for the stock. On February 22, 2024, Leerink Partners Initiated their recommendations, while on January 04, 2022, Barclays Downgrade their ratings for the stock with a price target of $7. Stock get a Sell rating from Goldman on August 27, 2021.
